SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 9, 2003 HALSEY DRUG CO., INC. 695 North Perryville Road, Rockford, Illinois 61107 (815-399-2060) Incorporated under the Commission File Number I.R.S. Employer laws of State of New York 1-10113 Identification Number 11-0853640 Item 7. Financial Statements and Exhibits. (c) Exhibits Exhibit Number Description ------ ----------- 99.1 Press Release of Halsey Drug Co., Inc. dated May 9, 2003 reporting results for the year ended December 31, 2002. Item 9. Regulation FD Disclosure. The Registrant is furnishing under Item 9 of this Current Report on Form 8-K: (i) Exhibit 99.1 consisting of a copy of the press release issued on May 9, 2003 reporting results for the year ended December 31, 2002. The statements in this Current Report on Form 8-K, including the exhibits, contain forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that forward-looking statements involve risk and uncertainties which may affect the Registrant's business prospects, including, economic, competitive, governmental, technological and other factors discussed in filings with the Securities and Exchange Commission. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. HALSEY DRUG CO., INC. By: /s/ Peter A. Clemens ----------------------------------------- Peter A. Clemens Vice President & Chief Financial Officer Date: May 9, 2003 EXHIBIT INDEX ------------- Exhibit Number Description ------ ----------- 99.1 Press Release of Halsey Drug Co., Inc. dated May 9, 2003 reporting results for the forth quarter and year ended December 31, 2002.